View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
December 9, 2009

US Personalised Medicine Market On the Up: PwC

The US market for personalised medicine is worth $232bn and is expected to grow by 11% annually, according to a report. The PricewaterhouseCoopers (PwC) report said that the market will grow to $452bn by 2015. Personalised medicine targets individualised treatment and care ba

By cms admin

The US market for personalised medicine is worth $232bn and is expected to grow by 11% annually, according to a report.

The PricewaterhouseCoopers (PwC) report said that the market will grow to $452bn by 2015.

Personalised medicine targets individualised treatment and care based on personal and genetic variation and is creating a booming market.

The core diagnostic and therapeutic segment of the market is comprised primarily of pharmaceutical, medical device and diagnostics companies and is estimated at $24bn.

This sector is expected to grow by 10% annually, reaching $42bn by 2015.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management